Terms: = Pancreatic cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Treatment
60 results:
1. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic pancreatic Surgery (TAPS) Consortium study.
Theijse RT; Stoop TF; Janssen QP; Prakash LR; Katz MHG; Doppenberg D; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG
Br J Surg; 2024 Mar; 111(3):. PubMed ID: 38456678
[TBL] [Abstract] [Full Text] [Related]
2. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
[TBL] [Abstract] [Full Text] [Related]
3. Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.
Verso M; Muñoz A; Connors JM
Intern Emerg Med; 2023 Sep; 18(6):1619-1634. PubMed ID: 37227679
[TBL] [Abstract] [Full Text] [Related]
4. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
[TBL] [Abstract] [Full Text] [Related]
5. Association of Radiation and Procarbazine Dose With Risk of Colorectal cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacological targeting of the receptor alk inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma.
Parejo-Alonso B; Royo-García A; Espiau-Romera P; Courtois S; Curiel-García Á; Zagorac S; Villaoslada I; Olive KP; Heeschen C; Sancho P
Biomed Pharmacother; 2023 Feb; 158():114162. PubMed ID: 36571997
[TBL] [Abstract] [Full Text] [Related]
7. Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction.
Wan YY; Miao CL; Liu SB; Zhang T; Luo CH
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1212-1215. PubMed ID: 36089724
[TBL] [Abstract] [Full Text] [Related]
8. Short- and long-term outcomes of laparoscopic versus open liver resection for large hepatocellular carcinoma: a propensity score study.
Zhang KJ; Liang L; Diao YK; Xie YM; Wang DD; Xu FQ; Ye TW; Lu WF; Cheng J; Shen GL; Yao WF; Lu Y; Xiao ZQ; Zhang JG; Zhang CW; Huang DS; Liu JW
Surg Today; 2023 Mar; 53(3):322-331. PubMed ID: 35986784
[TBL] [Abstract] [Full Text] [Related]
9. Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation.
De Pastena M; van Bodegraven EA; Mungroop TH; Vissers FL; Jones LR; Marchegiani G; Balduzzi A; Klompmaker S; Paiella S; Tavakoli Rad S; Groot Koerkamp B; van Eijck C; Busch OR; de Hingh I; Luyer M; Barnhill C; Seykora T; Maxwell T T; de Rooij T; Tuveri M; Malleo G; Esposito A; Landoni L; Casetti L; Alseidi A; Salvia R; Steyerberg EW; Abu Hilal M; Vollmer CM; Besselink MG; Bassi C
Ann Surg; 2023 May; 277(5):e1099-e1105. PubMed ID: 35797608
[TBL] [Abstract] [Full Text] [Related]
10. A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Salawu A; Hansen AR; Spreafico A; Al-Ezzi E; Webster S; Bedard PL; Doi J; Wang L; Siu LL; Abdul Razak AR
Target Oncol; 2022 May; 17(3):271-281. PubMed ID: 35635640
[TBL] [Abstract] [Full Text] [Related]
11. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
12. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of outcomes between secondary fully covered and uncovered self-expandable metal stents in the treatment of recurrent biliary obstruction of pancreatic cancer.
Kataoka K; Kawashima H; Ohno E; Ishikawa T; Mizutani Y; Iida T; Furukawa K; Nakamura M; Honda T; Ishigami M; Fujishiro M
Surg Endosc; 2022 Aug; 36(8):5676-5683. PubMed ID: 35020055
[TBL] [Abstract] [Full Text] [Related]
14. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
[No Abstract] [Full Text] [Related]
15. Anticancer drug resistance: An update and perspective.
Nussinov R; Tsai CJ; Jang H
Drug Resist Updat; 2021 Dec; 59():100796. PubMed ID: 34953682
[TBL] [Abstract] [Full Text] [Related]
16. The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer.
Umemoto K; Sunakawa Y
Crit Rev Oncol Hematol; 2021 Oct; 166():103465. PubMed ID: 34454058
[TBL] [Abstract] [Full Text] [Related]
17. Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis.
Hibino Y; Ito M; Satake T; Kondo S
ESMO Open; 2021 Aug; 6(4):100187. PubMed ID: 34118770
[TBL] [Abstract] [Full Text] [Related]
18. alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors.
De Rycke O; Walter T; Perrier M; Hentic O; Lombard-Bohas C; Coriat R; Cadiot G; Couvelard A; Ruszniewski P; Cros J; de Mestier L
Endocr Relat Cancer; 2021 Jun; 28(7):457-466. PubMed ID: 33979778
[TBL] [Abstract] [Full Text] [Related]
19. Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent alki Design.
Yan G; Zhong X; Pu C; Yue L; Shan H; Lan S; Zhou M; Hou X; Yang J; Li D; Fan S; Li R
J Med Chem; 2021 Feb; 64(3):1558-1569. PubMed ID: 33471528
[TBL] [Abstract] [Full Text] [Related]
20. Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
Khan T; Seddon AM; Dalgleish AG; Khelwatty S; Ioannou N; Mudan S; Modjtahedi H
Oncol Rep; 2020 Dec; 44(6):2581-2594. PubMed ID: 33125153
[TBL] [Abstract] [Full Text] [Related]
[Next]
